Products for Research Use Only
RegisterLogin

CRAC intermediate 1

CAT: 0804-HY-20587-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-20587-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors, detailed information can be found in Patent WO 2010122089 A1, intermediate 9.
CAS Number
1249343-86-9
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CRAC Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CRAC-intermediate-1.html
Concentration
10mM
Purity
98.46
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(C1=C(F)C=CC=C1F)NC2=NNC=C2
Molecular Formula
C10H7F2N3O
Molecular Weight
223.18
Precautions
H302, H315, H319, H335
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-20588-01CRAC intermediate 2
HY-122158CRAC channel inhibitor-1
HY-79253-01MMAF intermediate 1
HY-400684Tubulysin A intermediate-1
HY-P1358-01Alisporivir intermediate-1
HY-W076298-01Remdesivir intermediate-1
HY-41940-01Dasatinib intermediate-1
HY-47820-01Tesirine intermediate-1
HY-41047-01Taltobulin intermediate-1
HY-401505TD1092 intermediate-1

Alternative Products

CatalogName
T10884-01CRAC intermediate 1
T10885-01CRAC intermediate 2
A13753-25CRAC intermediate 2 25mg
A13753-5CRAC intermediate 2 5mg
A20601-200CRAC intermediate 1 200mg
A20601-10CRAC intermediate 1 10mg
A20601-5CRAC intermediate 1 5mg
A20601-100CRAC intermediate 1 100mg
A13753-200CRAC intermediate 2 200mg
A13753-100CRAC intermediate 2 100mg

Popular Products